JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M209676200 on November 5, 2002

J. Biol. Chem., Vol. 278, Issue 3, 1511-1517, January 17, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/3/1511    most recent
M209676200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pagani, F.
Right arrow Articles by Baralle, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pagani, F.
Right arrow Articles by Baralle, F. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Promoter Architecture Modulates CFTR Exon 9 Skipping*

Franco Pagani, Cristiana Stuani, Elisabetta Zuccato, Alberto R. KornblihttDagger §, and Francisco E. Baralle

From the International Centre for Genetic Engineering and Biotechnology, Padriciano 99, Trieste 34012, Italy and the Dagger  Laboratorio de Fisiología y Biología Molecular, Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Pabellón II (C1428EHA) Buenos Aires, Argentina

Using hybrid minigene experiments, we have investigated the role of the promoter architecture on the regulation of two alternative spliced exons, cystic fibrosis transmembrane regulator (CFTR) exon 9 and fibronectin extra domain-A (EDB). A specific alternative splicing pattern corresponded to each analyzed promoter. Promoter-dependent sensitivity to cotransfected regulatory splicing factor SF2/ASF was observed only for the CFTR exon 9, whereas that of the EDB was refractory to promoter-mediated regulation. Deletion in the CFTR minigene of the downstream intronic splicing silencer element binding SF2/ASF abolished the specific promoter-mediated response to this splicing factor. A systematic analysis of the regulatory cis-acting elements showed that in the presence of suboptimal splice sites or by deletion of exonic enhancer elements the promoter-dependent sensitivity to splicing factor-mediated inhibition was lost. However, the basal regulatory effect of each promoter was preserved. The complex relationships between the promoter-dependent sensitivity to SF2 modulated by the exon 9 definition suggest a kinetic model of promoter-dependent alternative splicing regulation that possibly involves differential RNA polymerase II elongation.


* This work was supported by Telethon-Italy Grant GGP02453 and by a grant from the Associasione Italiana Ricerca Cancro (AIRC).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ A Howard Hughes Medical Institute International Research Scholar and a career investigator of the Consejo Nacional de Investigaciones Científicas y Técnicas of Argentina.

To whom correspondence should be addressed. Tel: 39-040-3757337; Fax: 39-040-3757361; E-mail: baralle@icgeb.org.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DNA ResHome page
T.-M. Chern, N. Paul, E. van Nimwegen, and M. Zavolan
Computational Analysis of Full-length cDNAs Reveals Frequent Coupling Between Transcriptional and Splicing Programs
DNA Res, April 1, 2008; 15(2): 63 - 72.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Alpatov, Y. Shi, G. C. Munguba, B. Moghimi, J.-H. Joo, J. Bungert, and S. P. Sugrue
Corepressor CtBP and Nuclear Speckle Protein Pnn/DRS Differentially Modulate Transcription and Splicing of the E-Cadherin Gene
Mol. Cell. Biol., March 1, 2008; 28(5): 1584 - 1595.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. N. Dawson, V. Cantillana, L. Chen, and M. P. Vitek
The Tau N279K Exon 10 Splicing Mutation Recapitulates Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 Tauopathy in a Mouse Model
J. Neurosci., August 22, 2007; 27(34): 9155 - 9168.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Gendra, D. F. Colgan, B. Meany, and M. M. Konarska
A Sequence Motif in the Simian Virus 40 (SV40) Early Core Promoter Affects Alternative Splicing of Transcribed mRNA
J. Biol. Chem., April 20, 2007; 282(16): 11648 - 11657.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
N. N. Singh, R. N. Singh, and E. J. Androphy
Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes
Nucleic Acids Res., January 28, 2007; 35(2): 371 - 389.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
T. LENASI, B. M. PETERLIN, and P. DOVC
Distal regulation of alternative splicing by splicing enhancer in equine {beta}-casein intron 1
RNA, March 1, 2006; 12(3): 498 - 507.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. A. Mercado, Y. M. Ayala, M. Romano, E. Buratti, and F. E. Baralle
Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene
Nucleic Acids Res., October 27, 2005; 33(18): 6000 - 6010.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
D Baralle and M Baralle
Splicing in action: assessing disease causing sequence changes
J. Med. Genet., October 1, 2005; 42(10): 737 - 748.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. de la Grange, M. Dutertre, N. Martin, and D. Auboeuf
FAST DB: a website resource for the study of the expression regulation of human gene products
Nucleic Acids Res., July 28, 2005; 33(13): 4276 - 4284.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. A. Lewandowska, C. Stuani, A. Parvizpur, F. E. Baralle, and F. Pagani
Functional studies on the ATM intronic splicing processing element
Nucleic Acids Res., July 19, 2005; 33(13): 4007 - 4015.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Auboeuf, D. H. Dowhan, M. Dutertre, N. Martin, S. M. Berget, and B. W. O'Malley
A Subset of Nuclear Receptor Coregulators Act as Coupling Proteins during Synthesis and Maturation of RNA Transcripts
Mol. Cell. Biol., July 1, 2005; 25(13): 5307 - 5316.
[Full Text] [PDF]


Home page
RNAHome page
A. R. KORNBLIHTT, M. DE LA MATA, J. P. FEDEDA, M. J. MUNOZ, and G. NOGUES
Multiple links between transcription and splicing
RNA, October 20, 2004; 10(10): 1489 - 1498.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Auboeuf, D. H. Dowhan, X. Li, K. Larkin, L. Ko, S. M. Berget, and B. W. O'Malley
CoAA, a Nuclear Receptor Coactivator Protein at the Interface of Transcriptional Coactivation and RNA Splicing
Mol. Cell. Biol., January 1, 2004; 24(1): 442 - 453.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Nogues, M. J. Munoz, and A. R. Kornblihtt
Influence of Polymerase II Processivity on Alternative Splicing Depends on Splice Site Strength
J. Biol. Chem., December 26, 2003; 278(52): 52166 - 52171.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.